Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | +1.43% | -2.74% | -69.22% |
Apr. 18 | Immix Biopharma on Track to Dose First Patients with AL Amyloidosis Therapy by Mid-Year | MT |
Apr. 18 | Immix Biopharma, Inc. Announces on Track to Dose NXC-201 Patients in United States | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.22% | 56.22M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- IMMX Stock
- News Immix Biopharma, Inc.
- Sector Update: Health Care Stocks Steady Premarket Monday